Literature DB >> 16510091

[Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study].

Antonio Coca1, Antonio Dalfó, Enric Esmatjes, José Luis Llisterri, Jordi Ordóñez, Ramón Gomis, José Ramón González-Juanatey, Armando Martín-Zurro.   

Abstract

BACKGROUND AND
OBJECTIVE: The PREVENCAT study was designed to estimate the control of the main cardiovascular risk factors (CVRF) and their treatment in a sample of population having the diagnoses of hypertension (HT), type 2 diabetes mellitus (DM2) or hypercholesterolemia (HC) who was attended by primary care physicians in Spain. PATIENTS AND
METHOD: Cross-sectional study in patients with HT, DM2 and/or HC, who were consecutively recruited. We describe the treatments for HT, DM2 and HC and analyze and the association between several potential predictors and the control of these CVRF.
RESULTS: 2,649 patients were included in the study. 95% of HT patients were under treatment, as were 84% of DM2 and 71.4% of HC patients; most common drugs were diuretics, sulphonylureas and statins, respectively. Monotherapy was more frequent than combined therapy for hypertension treatment. The frequency of HT and DM2 treatment was similar among the subgroups defined by the presence or absence of the other two diagnoses. However, HC treatment was more common in the presence of DM2 (p = 0.001). Age, previous cardiovascular disease (CVD), DM2, obesity and sedentarism were all predictors of poor blood pressure control despite drug treatment. Age, previous CVD, HT and sedentarism were predictors of poor HC control.
CONCLUSIONS: CVRF treatment was high although heterogeneous and not based on the best available evidence. DM2, previous CVD and obesity were associated with insufficient blood pressure control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510091     DOI: 10.1157/13084868

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  4 in total

1.  [Lifestyles of subjects who take drugs for two or more cardiovascular risk factors. TAR-RISC Study].

Authors:  Josep Carles Llop Margalef; Silvia Hernández Anadón; Josep Bítria Ibars; Albert Josa; José María Crespo; Ferran Bejarano Romero; Carles Llor
Journal:  Aten Primaria       Date:  2010-05-20       Impact factor: 1.137

2.  [Cardiovascular risk factors: a follow up study in a non-diabetic population].

Authors:  María Vernet Vernet; María José Sender Palacios; Esther Jovell Fernández; Encarnació Tor Figueras; Ramón Casals Riera; Pere Larrosa Sàez
Journal:  Aten Primaria       Date:  2009-08-06       Impact factor: 1.137

3.  [Patient workload and costs, intensity and quality of family doctor prescriptions].

Authors:  Juan Simó Miñana; Miriam Calvo Pérez; José Luís Beltrán Brotóns
Journal:  Aten Primaria       Date:  2010-06-16       Impact factor: 1.137

4.  Effectiveness of standardized nursing care plans to achieve A1C, blood pressure, and LDL-C goals among people with poorly controlled type 2 diabetes mellitus at baseline: four-year follow-up study.

Authors:  J Cárdenas-Valladolid; A López-de Andrés; R Jiménez-García; M J de Dios-Duarte; P Gómez-Campelo; C de Burgos-Lunar; F J San Andrés-Rebollo; J C Abánades-Herranz; M A Salinero-Fort
Journal:  BMC Fam Pract       Date:  2018-07-24       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.